The next six months may be decisive for the biotech.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
After a solid Q4 result, analysts have turned more bullish on Seagate. Should investors follow suit?
Morgan Stanley raises price target on Cognizant stock. But CTSH shares are still under pressure today.
Mizuho upgraded Bloom Energy to Outperform from Neutral with a price target of $242, a 48% upside from Wednesday’s closing price.
Bloom Energy's blockbuster quarterly results finally hit the market a day late, and a fresh Wall Street upgrade is pouring fuel on a rally that's pulling the entire fuel-cell sector along for the ride.
Commvault (CVLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Talen Energy Corporation (TLN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Apple's earnings report comes days after the company launched Apple Upgrade in the U.S.—a program that BofA Securities says could improve affordability for consumers and help the company wrestle some control from wireless carriers. As part of Apple Upgrade, customers now have one- or two-year leasing options for iPhones and Apple Watches, and two- or three-year options for Macs and iPads. Apple has long offered trade-ins and financing plans, but "the new structure packages those familiar mechanics into a broader platform spanning major hardware categories," wrote Wamsi Mohan, an analyst at BofA.
The bank valued Core Scientific’s contracted portfolio at about $23 per share and assigned additional option value to 384 MW of interconnection-backed expansion capacity.
Goldman Sachs upgraded Chinese EV maker Nio despite the fact the country's electric vehicle market continues to struggle. Shares are up about 7% this week.
Goldman Sachs upgraded Chinese EV maker Nio despite the fact the country's electric vehicle market continues to struggle. Shares are up about 7% this week.
Investing.com -- HSBC downgraded Procter & Gamble to "Hold" from "Buy" and cut its price target to $149 from $182, saying the consumer goods giant's reinvestment in marketing and innovation has yet to translate into stronger sales volumes or margin recovery despite continued spending.
Investing.com -- Mizuho upgraded Bloom Energy to "Outperform" from "Neutral" and set a $242 price target, citing stronger-than-expected execution, accelerating margin expansion and improving operating leverage, while arguing the recent share-price pullback has created an attractive entry point.
Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls
Investing.com -- JPMorgan downgraded Pirelli to Neutral from Overweight on Thursday after the tire maker reported first-half results the bank described as solid, citing limited upside at its price target.
Wall Street giants including Goldman Sachs, Barclays, and Jefferies have cut their price targets on HOOD stock on Thursday. Lower price targets were given despite Robinhood Markets reporting strong Q2 2026 financial results, with earnings per share and revenues beating Wall Street estimates. Ad Ad Goldman Sachs Holds Buy Rating, But Trims HOOD Stock Price
Shares of Microsoft (NASDAQ:MSFT) are up 9% in early Thursday trading, changing hands at $427 after the software giant delivered a fiscal fourth-quarter blowout and crossed a symbolic Azure milestone. The pop lifts the stock off Wednesday’s $390.54 close and pushes it back toward levels last seen in the spring. As of yesterday’s close, Microsoft ... Microsoft Surges 9% as Azure Tops $100B and Q4 Beat Lifts Most Price Targets
Nebius was just upgraded to a "Buy" rating by analysts at Freedom Capital
The revenue shortfall and the record margin came out of the same decision, and management raised its full-year outlook on the strength of it.
The market looked past a small earnings beat to a profit that is still shrinking and a raised target that leans heavily on the back half of the year.
7.51am: Rolls raises guidance after strong first half Rolls-Royce has raised its full-year guidance after first-half operating profit jumped 46%, as improved margins across all three divisions extended the engine maker's turnaround. Underlying operating profit increased to £2.5 billion...
The group now expects full-year adjusted organic earnings before interest, taxes and amortization growth of between 14% and 19%, up from 10% and 15%.
Klarna Group (NYSE:KLAR) has been selected as the leasing provider for Apple Upgrade, Apple's new hardware leasing program in the United States. The program supports financing for Apple hardware across in-store and online checkout channels. Klarna Group now sits inside a high-profile consumer hardware program with Apple Upgrade in the US. The stock closed at $18.71 and is down 1.7% over the past week, 7.8% over the past month, and 34.5% year to date. Those moves frame the Apple partnership...
Phillip Securities upgraded Alphabet after its earnings selloff but lowered forecasts to account for enormous AI spending.
Caterpillar stock sinks as Baird downgrades it to Neutral. Here’s why the firm turned bearish on CAT shares today.
The brokerage stated that growing opposition to data centre construction could weigh on demand for construction equipment and compress Caterpillar's valuation.
Ford stock rallies as Citi upgrades it to "Buy" after an upbeat Q2 report and encouraging future guidance. Here’s how far the firm believes F shares could go in 2026.
Wall Street is watching Akamai Technologies closely after a blockbuster deal reshaped the company's growth story earlier this year. Morgan Stanley reaffirmed its “Overweight” rating on Akamai (AKAM) in a July 27 research note shared with me, keeping its price target at $165, roughly 48% above the ...
COCO's brand momentum, international growth and Copra acquisition are driving a stronger outlook, while rising costs and capacity needs remain key risks.
AbbVie still looks like a compelling buy at its all-time high.